Levosimendan is approved in
Levosimendan is a calcium sensitizer -- it increases the sensitivity of the hea to calcium, thus increasing cardiac contractility without a rise in intracellular calcium.Has been approved for use in acute cardiac failure in EuropeKatzung 13e pg: 220
Hea failure
Kidney failure
Liver failure
Endocrine crisis
Muscle relaxants